IL36950A - Carcinoembryonic antigen,its production and use - Google Patents
Carcinoembryonic antigen,its production and useInfo
- Publication number
- IL36950A IL36950A IL36950A IL3695071A IL36950A IL 36950 A IL36950 A IL 36950A IL 36950 A IL36950 A IL 36950A IL 3695071 A IL3695071 A IL 3695071A IL 36950 A IL36950 A IL 36950A
- Authority
- IL
- Israel
- Prior art keywords
- production
- carcinoembryonic antigen
- carcinoembryonic
- antigen
- Prior art date
Links
- 102000012406 Carcinoembryonic Antigen Human genes 0.000 title 1
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 title 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J47/00—Ion-exchange processes in general; Apparatus therefor
- B01J47/02—Column or bed processes
- B01J47/04—Mixed-bed processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
- A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/26—Cation exchangers for chromatographic processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J47/00—Ion-exchange processes in general; Apparatus therefor
- B01J47/014—Ion-exchange processes in general; Apparatus therefor in which the adsorbent properties of the ion-exchanger are involved, e.g. recovery of proteins or other high-molecular compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3007—Carcino-embryonic Antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57473—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/804—Radioisotope, e.g. radioimmunoassay
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/825—Pretreatment for removal of interfering factors from sample
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/828—Cancer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Animal Behavior & Ethology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4252670A | 1970-06-01 | 1970-06-01 | |
| US11028871A | 1971-01-27 | 1971-01-27 | |
| US13340471A | 1971-04-12 | 1971-04-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL36950A0 IL36950A0 (en) | 1971-11-29 |
| IL36950A true IL36950A (en) | 1975-04-25 |
Family
ID=27366145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL36950A IL36950A (en) | 1970-06-01 | 1971-05-28 | Carcinoembryonic antigen,its production and use |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3697638A (nl) |
| JP (1) | JPS542247B1 (nl) |
| BE (1) | BE767801A (nl) |
| CA (1) | CA965351A (nl) |
| CH (4) | CH596554A5 (nl) |
| DE (1) | DE2126680B2 (nl) |
| DK (1) | DK132739C (nl) |
| FR (1) | FR2095644A5 (nl) |
| GB (4) | GB1358827A (nl) |
| IL (1) | IL36950A (nl) |
| IT (1) | IT998033B (nl) |
| NL (1) | NL161457C (nl) |
| SE (5) | SE400083B (nl) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3867363A (en) * | 1970-06-01 | 1975-02-18 | Hans John Hansen | Carcinoembryonic antigens |
| US3956258A (en) * | 1972-05-12 | 1976-05-11 | Hoffmann-La Roche Inc. | Carcinoembryonic antigens |
| CH583036A5 (nl) * | 1972-05-12 | 1976-12-31 | Hoffmann La Roche | |
| ZA723264B (en) * | 1972-10-13 | 1974-08-28 | H Van Til | Improvements in toys |
| US3867518A (en) * | 1973-03-09 | 1975-02-18 | Hoffmann La Roche | Radioimmunoassay for insulin |
| US3927193A (en) * | 1973-05-18 | 1975-12-16 | Hoffmann La Roche | Localization of tumors by radiolabelled antibodies |
| US4022876A (en) * | 1973-06-21 | 1977-05-10 | Stanford Research Institute | Mass spectrometric immunoassay |
| US4132769A (en) * | 1974-10-30 | 1979-01-02 | Osther Kurt B | Cancer antigen, cancer therapy, and cancer diagnosis |
| US4152410A (en) * | 1975-09-03 | 1979-05-01 | Eisai Co., Ltd. | Diagnosis reagent for neoplasm and method for diagnosis of neoplasm |
| US4132767A (en) * | 1976-04-05 | 1979-01-02 | Eisai Co., Ltd. | Preparation of α-L antibody, purification of α-L antigen and reagent for detection of α-L antibody and α-L antigen |
| US4144031A (en) * | 1976-04-19 | 1979-03-13 | International Radioimmune Systems, Inc. | Cell test for detecting human chorionic gonadotropin |
| US4145336A (en) * | 1976-04-30 | 1979-03-20 | Scripps Clinic And Research Foundation | Carcinoembryonic antigen isomer |
| US4140753A (en) * | 1976-04-30 | 1979-02-20 | Scripps Clinic & Research Foundation | Diagnostic method and reagent |
| US4146603A (en) * | 1977-02-18 | 1979-03-27 | Research Corporation | Tumor specific glycoproteins and method for detecting tumorigenic cancers |
| US4234476A (en) * | 1978-03-07 | 1980-11-18 | Research Corporation | Application of protein-protein interaction as an assay for the detection of cancer |
| US4228127A (en) * | 1978-10-06 | 1980-10-14 | International Radioimmune Systems, Inc. | Kit for detecting human chorionic gonadotropin |
| US4241044A (en) * | 1978-12-28 | 1980-12-23 | Abbott Laboratories | Method of diagnosing cancer by detecting elevated anti-T antibody activity |
| US4349528A (en) * | 1979-11-21 | 1982-09-14 | The Wistar Institute | Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen |
| US4299815A (en) * | 1980-02-08 | 1981-11-10 | Hoffmann-La Roche Inc. | Carcinoembryonic antigen determination |
| US4578349A (en) * | 1982-04-08 | 1986-03-25 | Abbott Laboratories | Immunoassay for carcinoembryonic antigen (CEA) |
| ATE28937T1 (de) * | 1982-08-09 | 1987-08-15 | Centocor Inc | Immunotest fuer kohlehydrat-antigen-determinant. |
| DK557483A (da) * | 1982-12-06 | 1984-06-07 | Hoffmann La Roche | Fremgangsmaade til bestemmelse af cea |
| US4962187A (en) * | 1984-11-28 | 1990-10-09 | Cota Biotech | Common antigen for colorectal and mucinous ovarian tumors and process for isolating the same |
| US5030559A (en) * | 1986-04-01 | 1991-07-09 | Board Of Regents, The University Of Texas System | Methods and compositions for the identification of metastatic human tumors |
| US6022958A (en) * | 1986-08-13 | 2000-02-08 | Bayer Corporation | cDNAs coding for members of the carcinoembryonic antigen family |
| US5217903A (en) * | 1990-05-15 | 1993-06-08 | Trustees Of Boston University | Measuring connective tissue breakdown products in body fluids |
-
1971
- 1971-04-12 US US133404A patent/US3697638A/en not_active Expired - Lifetime
- 1971-05-19 CH CH737871A patent/CH596554A5/xx not_active IP Right Cessation
- 1971-05-26 FR FR7119009A patent/FR2095644A5/fr not_active Expired
- 1971-05-28 BE BE767801A patent/BE767801A/xx not_active IP Right Cessation
- 1971-05-28 DK DK260171A patent/DK132739C/da not_active IP Right Cessation
- 1971-05-28 DE DE2126680A patent/DE2126680B2/de not_active Ceased
- 1971-05-28 SE SE7106985A patent/SE400083B/xx unknown
- 1971-05-28 IL IL36950A patent/IL36950A/xx unknown
- 1971-05-29 IT IT25226/71A patent/IT998033B/it active
- 1971-06-01 JP JP3751971A patent/JPS542247B1/ja active Pending
- 1971-06-01 GB GB4418573A patent/GB1358827A/en not_active Expired
- 1971-06-01 GB GB1830971*[A patent/GB1356911A/en not_active Expired
- 1971-06-01 GB GB4418473A patent/GB1356912A/en not_active Expired
- 1971-06-01 NL NL7107499.A patent/NL161457C/nl not_active IP Right Cessation
- 1971-06-01 GB GB4418773A patent/GB1358828A/en not_active Expired
- 1971-06-01 CA CA114,457A patent/CA965351A/en not_active Expired
-
1974
- 1974-10-18 SE SE7413186A patent/SE397139B/xx unknown
- 1974-10-18 SE SE7413185A patent/SE419481B/xx unknown
- 1974-10-18 SE SE7413187A patent/SE419482B/xx unknown
- 1974-10-18 SE SE7413184A patent/SE421425B/xx unknown
-
1977
- 1977-01-24 CH CH81777A patent/CH606067A5/xx not_active IP Right Cessation
- 1977-01-24 CH CH81977A patent/CH604665A5/xx not_active IP Right Cessation
- 1977-01-24 CH CH81877A patent/CH595636A5/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SE419482B (sv) | 1981-08-03 |
| DE2126680A1 (de) | 1971-12-09 |
| GB1358828A (en) | 1974-07-03 |
| DK132739C (da) | 1976-07-12 |
| FR2095644A5 (nl) | 1972-02-11 |
| DE2126680B2 (de) | 1980-10-09 |
| IL36950A0 (en) | 1971-11-29 |
| GB1358827A (en) | 1974-07-03 |
| SE7413186L (nl) | 1974-10-18 |
| CH596554A5 (nl) | 1978-03-15 |
| SE419481B (sv) | 1981-08-03 |
| CH604665A5 (nl) | 1978-09-15 |
| CA965351A (en) | 1975-04-01 |
| JPS542247B1 (nl) | 1979-02-05 |
| SE421425B (sv) | 1981-12-21 |
| GB1356912A (en) | 1974-06-19 |
| SE7413184L (nl) | 1974-10-18 |
| CH606067A5 (nl) | 1978-10-13 |
| SE400083B (sv) | 1978-03-13 |
| SE7413187L (nl) | 1974-10-18 |
| US3697638A (en) | 1972-10-10 |
| NL161457B (nl) | 1979-09-17 |
| SE7413185L (nl) | 1974-10-18 |
| IT998033B (it) | 1976-01-20 |
| DK132739B (da) | 1976-02-02 |
| NL7107499A (nl) | 1971-12-03 |
| GB1356911A (en) | 1974-06-19 |
| NL161457C (nl) | 1980-02-15 |
| CH595636A5 (nl) | 1978-02-15 |
| BE767801A (fr) | 1971-11-29 |
| SE397139B (sv) | 1977-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL36950A (en) | Carcinoembryonic antigen,its production and use | |
| IL34722A0 (en) | Carcinoembryonic antigen | |
| ZA713624B (en) | Polyetheramines,their production and use | |
| EG10637A (en) | New aminophenylamidines,their production and their pharmaceutical use | |
| ZA713765B (en) | New aminophenylamidines,their production and their medicinal use | |
| ZA713764B (en) | New aminophenyl-cycloamidines,their production and their medicinal use | |
| IL38380A0 (en) | Azo compounds,their manufacture and use | |
| CY830A (en) | New penicillins, their preparation and their use | |
| IL36356A0 (en) | Beta-rhodomycin v,its production and therapeutical use | |
| CA973178A (en) | 1-alkenyl-9,10-anthraquinones and their production | |
| CA967151A (en) | Nitrodiphenylamines, their manufacture and use | |
| ZA713274B (en) | New penicillins,their preparation and their use | |
| JPS56151614A (en) | Packer | |
| ZA712627B (en) | Azo compounds,their manufacture and use | |
| ZA71641B (en) | New azo compounds,their production and use | |
| ZA71167B (en) | Anti-sera | |
| ZA713063B (en) | Carcinoembryonic antigen | |
| AU459764B2 (en) | Carcinoembryonic antigen | |
| AU460071B2 (en) | Carcinoembryonic antigen | |
| ZA718144B (en) | Unsaturated polyesters,their production and use | |
| AU2951671A (en) | Carcinoembryonic antigen | |
| AU1646270A (en) | Carcinoembryonic antigen | |
| IL37771A (en) | 2-alkylsulphonylaminomethyl-1,4-benzodioxanes | |
| IL37724A0 (en) | N-substituted-2,3-dihydro-2-oxo-5-phenyl-1h-1,4-benzodiazepine-1-carboxamides | |
| IL38183A0 (en) | Herbicidally-active substituted phenylthiocarbamates and their manufacture and use |